The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
29
No.
38
October 17, 2003
- Medicare plans to cut oncology payments on Jan. 1 unless Congress intervenes.
- Also Lance Armstrong visits NIH, Washington, for Tour of Hope event.
- Letrozole cuts risk of recurrent breast cancer in post-menopausal women.
- NIH funds four centers to study breast cancer and the environment.
- AACI to coordinate clinical trials project.
- NCI director recognizes work of staff.
- Funding opportunities listed.
TCL
Vol.
29
No.
39
October 24, 2003
- Study tests a “truth” in radiation oncology, raises questions about anemia treatment.
- Also MSKCC picks David Kissane to succeed Jimmie Holland as chairman of psychiatry and behavioral sciences.
- NCI Unconventional Innovations Program releases Broad Agency Announcement.
- Leukemia & Lymphoma Society offers translational research grants.
TCL
Vol.
29
No.
40
October 31, 2003
- NCI director apologizes to cancer centers for inaction on working group report.
- Karen Antman recruited to NCI on an IPA to oversee changes to centers, SPORE programs.
- Also M.D. Anderson awarded three new, one renewal SPORE grant.
- Duke wins Avon-NCI funding.
- CMS to delay final rule publication for oncology.
- Former NCAB chairman, President’s Cancer Panel member Paul Calabresi dead at 73.
CCL
Vol.
26
No.
10
October 31, 2003
- Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds
- Novel Antifungal Agent Highly Active Against Esophageal Candidiasis
- Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia
- Cholesterol-Lowering Drugs May Prevent Breast Cancer
- Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds
- NCCN Updates Breast Cancer Guidelines for Patients
- Lung Cancer Clinical Trials Cost-Effective Alternative
- Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress
- New Drug Reduces Nausea and Vomiting
- Clinical Trials Approved By NCI
TCL
Vol.
29
No.
41
November 07, 2003
- FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.
- Also STAR trial can be completed with fewer women than planned, NSABP says.
- NCCF, Ad Council plan public service ads on childhood cancer.
- MSKCC hopes to raise $1 billion in five-year campaign.
TCL
Vol.
29
No.
42
November 14, 2003
- Congressional committee investigates former NCI Director Richard Klausner’s role in $40 million Harvard contract; NIH begins internal review. Klausner: investigation casts “strange innuendoes.” Text of committee’s letter.
- Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.
- NCI program announcement available, contract awards listed.
TCL
Vol.
29
No.
44
November 28, 2003
- NCI plans 11-16 percent budget cuts in new grants to maintain R01 payline at 20th percentile.
- Also Kevin Cullen named director, Univ. of Maryland Greenebaum Cancer Center.
- Congress enacts Medicare reform, bill cuts oncology reimbursement.
- Congress gives FDA authority to require pediatric clinical trials.
- NCI to release RFP for Cancer Information Service recompetition.
- November issue of Business & Regulatory Report included.
